A systematic review and meta-analysis of clinicopathologic factors associated with adverse oncologic outcomes in bladder cancer patients undergoing radical cystectomy: Evidence from multivariable survival prediction models [0.03%]
系统评价和meta-分析：根治性膀胱切除术膀胱癌患者预后不良的临床病理因素：多变量生存预测模型的证据
Alberto Artiles Medina,José Daniel Subiela,Alfonso Muriel García et al.
Alberto Artiles Medina et al.
This systematic review aimed to identify robust clinicopathologic predictors of overall (OS), cancer-specific (CSS), and recurrence-free survival (RFS) following radical cystectomy (RC) from published prediction models. PRISMA (Preferred Re...
Predictive value of the HAS-BLED score in the course of radical cystectomy: A pilot study [0.03%]
HAS-BLED评分在根治性膀胱切除术中预测价值的初步研究
Enis Mert Yorulmaz,Yigit Akin,Kursad Donmez et al.
Enis Mert Yorulmaz et al.
Objective: To evaluate the predictive value of the preoperative HAS-BLED score in estimating clinically significant blood loss in the course of radical cystectomy. ...
Specialty differences in treatment recommendations for low-risk prostate cancer [0.03%]
低危前列腺癌治疗建议的专科差异
Jinping Xu,Justin Woo,James Janisse et al.
Jinping Xu et al.
Purpose: To identify physician characteristics and beliefs associated with active surveillance (AS) recommendation by urologists and radiation oncologists for men with low-risk prostate cancer (LRPC). ...
Presentation, management, and outcomes of testicular germ cell tumors by age [0.03%]
年龄别睾丸生殖细胞肿瘤的诊断、治疗和预后
Joseph G Cheaib,Carlos A Rivera López,Alyssa Arbuiso et al.
Joseph G Cheaib et al.
Objective: Although testicular germ cell tumors (TGCTs) most commonly affect younger men, there has been an increase in their incidence among men older than 45 years in the past 2 decades. We sought to characterize differ...
The evolving global burden of kidney cancer: A comparative analysis of trends in China and worldwide with projections to 2041 [0.03%]
全球肾癌负担的变化：中国与全世界趋势的比较分析及2041年预测
Qing Yu,Yifan Zhang,Lin Qiao et al.
Qing Yu et al.
Background: Kidney cancer (KC) is a significant global health concern. This study comprehensively assesses its burden in China versus global trends to inform strategic responses. ...
Venous thromboembolism in patients with urothelial carcinoma receiving systemic therapy [0.03%]
接受系统治疗的尿路上皮癌患者的静脉血栓栓塞事件
Irene Huebner-Resch,Nicolai A Huebner,Regina Girgis et al.
Irene Huebner-Resch et al.
Background: Patients with urothelial carcinoma (UC) undergoing systemic therapy face an increased risk of venous thromboembolism (VTE). While the Khorana Risk Score (KRS) is widely applied in oncology to predict VTE, its ...
Automation of four nephrometry scores using 3D models in renal cell carcinoma [0.03%]
基于3D模型的肾细胞癌四种肾自动评分系统
Saar Vermijs,Joris Vangeneugden,Lara Demeyere et al.
Saar Vermijs et al.
Objectives: Nephrometry scores quantify renal tumor complexity to standardize reporting, however, manual calculation is time-consuming and prone to interobserver variability. Furthermore, 2-dimensional preoperative imagin...
An integrated restricted mean survival time-based evaluation of efficacy, toxicity, and cost in first-line immunotherapy regimens for metastatic renal cell carcinoma [0.03%]
基于整合的限制均生存时间法评估一线免疫治疗方案在转移性肾细胞癌中的疗效、毒性和成本
Yudai Ishiyama,Arjun Venkatesh,Joseph McGrath et al.
Yudai Ishiyama et al.
Purposes: To evaluate first-line metastatic renal cell carcinoma regimens using restricted mean survival time (RMST), which directly conveys absolute survival benefit, integrated with toxicity and cost. ...